1-7 of 7
Natarajan Muthusamy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor–Mediated Natural Killer Cell Function

Free
Andrew Stiff, Prashant Trikha, Bethany Mundy-Bosse, Elizabeth McMichael, Thomas A. Mace, Brooke Benner, Kari Kendra, Amanda Campbell, Shalini Gautam, David Abood, Ian Landi, Vincent Hsu, Megan Duggan, Robert Wesolowski, Matthew Old, John Harrison Howard, Lianbo Yu, Nancy Stasik, Thomas Olencki, Natarajan Muthusamy, Susheela Tridandapani, John C. Byrd, Michael Caligiuri, William E. Carson
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (8): 1891–1904.
https://doi.org/10.1158/1078-0432.CCR-17-0691
Published: 12 April 2018
View articletitled, Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor–Mediated Natural Killer Cell Function
Open the PDF for Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor–Mediated Natural Killer Cell Function in another window
Includes: Supplementary data
Journal Articles

Targeted Delivery of microRNA-29b by Transferrin-Conjugated Anionic Lipopolyplex Nanoparticles: A Novel Therapeutic Strategy in Acute Myeloid Leukemia

Free
Xiaomeng Huang, Sebastian Schwind, Bo Yu, Ramasamy Santhanam, Hongyan Wang, Pia Hoellerbauer, Alice Mims, Rebecca Klisovic, Alison R. Walker, Kenneth K. Chan, William Blum, Danilo Perrotti, John C. Byrd, Clara D. Bloomfield, Michael A. Caligiuri, Robert J. Lee, Ramiro Garzon, Natarajan Muthusamy, Ly James Lee, Guido Marcucci
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (9): 2355–2367.
https://doi.org/10.1158/1078-0432.CCR-12-3191
Published: 30 April 2013
View articletitled, Targeted Delivery of microRNA-29b by Transferrin-Conjugated Anionic Lipopolyplex Nanoparticles: A Novel Therapeutic Strategy in Acute Myeloid Leukemia
Open the PDF for Targeted Delivery of microRNA-29b by Transferrin-Conjugated Anionic Lipopolyplex Nanoparticles: A Novel Therapeutic Strategy in Acute Myeloid Leukemia in another window
Includes: Supplementary data
Journal Articles

Milatuzumab-Conjugated Liposomes as Targeted Dexamethasone Carriers for Therapeutic Delivery in CD74+ B-cell Malignancies

Free
Yicheng Mao, Georgia Triantafillou, Erin Hertlein, William Towns, Matthew Stefanovski, Xiaokui Mo, David Jarjoura, Mitch Phelps, Guido Marcucci, Ly James Lee, David M. Goldenberg, Robert J. Lee, John C. Byrd, Natarajan Muthusamy
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (2): 347–356.
https://doi.org/10.1158/1078-0432.CCR-12-2046
Published: 16 January 2013
View articletitled, Milatuzumab-Conjugated Liposomes as Targeted Dexamethasone Carriers for Therapeutic Delivery in CD74+ B-cell Malignancies
Open the PDF for Milatuzumab-Conjugated Liposomes as Targeted Dexamethasone Carriers for Therapeutic Delivery in CD74+ B-cell Malignancies in another window
Includes: Supplementary data
Journal Articles

A Phase I Dose-Finding Trial of Recombinant Interleukin-21 and Rituximab in Relapsed and Refractory Low Grade B-cell Lymphoproliferative Disorders

Free
John M. Timmerman, John C. Byrd, David J. Andorsky, Reiko E. Yamada, Janet Kramer, Natarajan Muthusamy, Naomi Hunder, John M. Pagel
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (20): 5752–5760.
https://doi.org/10.1158/1078-0432.CCR-12-0456
Published: 14 October 2012
View articletitled, A Phase I Dose-Finding Trial of Recombinant Interleukin-21 and Rituximab in Relapsed and Refractory Low Grade B-cell Lymphoproliferative Disorders
Open the PDF for A Phase I Dose-Finding Trial of Recombinant Interleukin-21 and Rituximab in Relapsed and Refractory Low Grade B-cell Lymphoproliferative Disorders in another window
Includes: Supplementary data
Journal Articles

FTY720 Shows Promising In vitro and In vivo Preclinical Activity by Downmodulating Cyclin D1 and Phospho-Akt in Mantle Cell Lymphoma

Free
Qing Liu, Lapo Alinari, Ching-Shih Chen, Fengting Yan, James T. Dalton, Rosa Lapalombella, Xiaoli Zhang, Rajeswaran Mani, Teresa Lin, John C. Byrd, Robert A. Baiocchi, Natarajan Muthusamy
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (12): 3182–3192.
https://doi.org/10.1158/1078-0432.CCR-09-2484
Published: 14 June 2010
View articletitled, FTY720 Shows Promising In vitro and In vivo Preclinical Activity by Downmodulating Cyclin D1 and Phospho-Akt in Mantle Cell Lymphoma
Open the PDF for FTY720 Shows Promising In vitro and In vivo Preclinical Activity by Downmodulating Cyclin D1 and Phospho-Akt in Mantle Cell Lymphoma in another window
Journal Articles

Reciprocal Regulation of Activating and Inhibitory Fcγ Receptors by TLR7/8 Activation: Implications for Tumor Immunotherapy

Free
Jonathan P. Butchar, Payal Mehta, Steven E. Justiniano, Kristan D. Guenterberg, Sri-Vidya Kondadasula, Xiaokui Mo, Mahesh Chemudupati, Thirumala-Devi Kanneganti, Amal Amer, Natarajan Muthusamy, David Jarjoura, Clay B. Marsh, William E. Carson, III, John C. Byrd, Susheela Tridandapani
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7): 2065–2075.
https://doi.org/10.1158/1078-0432.CCR-09-2591
Published: 31 March 2010
View articletitled, Reciprocal Regulation of Activating and Inhibitory Fcγ Receptors by TLR7/8 Activation: Implications for Tumor Immunotherapy
Open the PDF for Reciprocal Regulation of Activating and Inhibitory Fcγ Receptors by TLR7/8 Activation: Implications for Tumor Immunotherapy in another window
Journal Articles

A Novel Raji-Burkitt's Lymphoma Model for Preclinical and Mechanistic Evaluation of CD52-Targeted Immunotherapeutic Agents

Free
Rosa Lapalombella, Xiaobin Zhao, Georgia Triantafillou, Bo Yu, Yan Jin, Gerard Lozanski, Carolyn Cheney, Nyla Heerema, David Jarjoura, Amy Lehman, L. James Lee, Guido Marcucci, Robert J. Lee, Michael A. Caligiuri, Natarajan Muthusamy, John C. Byrd
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (2): 569–578.
https://doi.org/10.1158/1078-0432.CCR-07-1006
Published: 25 January 2008
View articletitled, A Novel Raji-Burkitt's Lymphoma Model for Preclinical and Mechanistic Evaluation of CD52-Targeted Immunotherapeutic Agents
Open the PDF for A Novel Raji-Burkitt's Lymphoma Model for Preclinical and Mechanistic Evaluation of CD52-Targeted Immunotherapeutic Agents in another window